What Sanfer does

Laboratorios Sanfer, S.A. de C.V. is a privately held Mexican multinational pharmaceutical company founded in 1941, headquartered in Mexico City, with operations in more than 25 countries across Latin America, the Caribbean, North America, Europe, Africa, the Middle East, and Asia. The company manufactures, markets, and distributes prescription medications, over-the-counter (OTC) consumer health products, animal health products (vaccines, antibiotics, antiparasitics, diagnostics), and poultry genetics through 20 manufacturing sites and a workforce of more than 12,000 employees. Sanfer's therapeutic footprint spans sterile injectables (ampoules, vials, lyophilized, prefilled syringes), oral solids and suspensions, semisolids, soft gelatin capsules, oncological steriles, antibiotics, and biologics, with capabilities reinforced by acquisitions including Probiomed (biotech, 2021) and Vitalis (Colombian sterile injectables leader, 2024).

Sanfer operates through a portfolio of legacy and acquired brands — including Mavi Farmacéutica, More Pharma, Pharmadorf (Argentina), Laboratorios Bussie and Labinco (Colombia), Laboratorios Pasteur (Chile), and Laboratorios Portugal (Peru) — alongside sub-brands such as Sanfer Salud Animal, Sanfer ALPES/IMSA (poultry genetics), and Sanfer Conecta (a digital platform providing healthcare professionals with access to more than 300,000 medical books, articles, webinars, and 3D anatomical models). The company sells through a multi-channel distribution network: retail pharmacy chains, mass retailers, e-commerce platforms (Amazon, Cornershop, Rappi, Farmalisto), and the Sanfer Conecta app for healthcare professionals.

Sanfer's commercial model is a sales-led, multi-channel distribution operation across prescription, OTC, animal health, and biologics, with revenue derived from unit sales of branded pharmaceutical products to consumers via pharmacies and retailers, to veterinarians and animal health providers, and to healthcare institutions across Latin America. Quality and regulatory certifications from COFEPRIS, INVIMA, DIGEMID, EMA, ISO, and FAMI-QS underpin the international expansion. The company has pursued an aggressive inorganic growth strategy, backed by institutional capital from La Caisse and General Atlantic (a $500M round in 2019), with recent strategic moves including the Vitalis acquisition (2024) and an exclusive distribution partnership with Hanmi Pharmaceutical for GLP-1 and diabetes therapies in Mexico (2026).

Name

Sanfer

Legal name

Laboratorios Sanfer, S.A. de C.V.

Website

https://sanfer.com.mx

Company type

Private

Founded year

1941

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Sanfer is a privately held Mexican multinational pharmaceutical company founded in 1941 that manufactures and distributes prescription, OTC, animal health, and biologic products through 20 manufacturing sites across 25+ countries, serving consumers, healthcare professionals, and veterinarians in Latin America.

Ownership category

akta.pro rank

Product category

Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Animal Food Manufacturing (3111)

SIC

Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836), Agricultural Prod-Livestock & Animal Specialties (200)

akta.pro primary industry

Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK)

akta.pro secondary industry

Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO) (HLAMAKAI)

Keywords

• Prescription pharmaceuticals
• Over-the-counter medications
• Animal health products
• Sterile injectables manufacturing
• Pharmaceutical distribution

Headquarters

HQ city

Mexico City

HQ country

Mexico

HQ region

Latin America

Offices9 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Prescription Medications: Prescription pharmaceutical products sold through pharmacies and healthcare providers in Mexico and Latin America
2. Over-the-Counter (OTC) Products: OTC pharmaceutical and consumer health products sold directly to consumers through pharmacies and retail chains
3. Animal Health Products: Veterinary pharmaceuticals, vaccines, and health products for animals sold to veterinarians and animal health providers
4. Poultry Genetics: Poultry genetics products through Sanfer ALPES and IMSA for the pharmaceutical and agricultural markets

Go-to-market motion1 record

Distribution channels6 records

Marketing channels8 records

Core offering

Laboratorios Sanfer manufactures, markets, and sells branded prescription and over-the-counter pharmaceutical products across multiple therapeutic areas through 20 manufacturing sites in Mexico and Latin America. The company also produces animal health pharmaceuticals, vaccines, and diagnostics through its Sanfer Salud Animal division, and operates integrated poultry genetics businesses (Sanfer ALPES and Sanfer IMSA). It supplements its product portfolio with the Sanfer Conecta digital platform that gives healthcare professionals access to product information, a medical library, and clinical resources.

Product overview

Laboratorios Sanfer is a leading Mexican pharmaceutical company with operations in 25+ countries across Latin America, operating as a diversified pharmaceutical group. The company offers a comprehensive portfolio of prescription medications, OTC (over-the-counter) products, nutraceuticals/supplements, and animal health products through multiple divisions and acquired brands. The core product ecosystem includes Sanfer Conecta, a digital platform for healthcare professionals providing access to product catalogs, medical libraries, webinars, and 3D anatomical models. The OTC portfolio includes analgesic/antipyretic products (AC-Fast, Algitrin, Tabalón, Lonol), antihistamines (Andantol), gastrointestinal products (Treda, Optazol-KO), antifungal products (Desenex, Ting), and wound care products (Microdacyn). The nutraceutical line includes Biometrix variants (Performance, AOX, Q-10), Meta-R metabiotics, and Eternal Vitamin E supplements. Animal health offerings are provided through Sanfer Salud Animal with vaccines, antibiotics, and diagnostic products. Sanfer has expanded through strategic acquisitions including Vitalis (sterile injectables), Probiomed (biotech), Mavi Farmacéutica, More Pharma, Laboratorios Portugal, Laboratorios Pasteur, Laboratorios Bussie, Labinco, Pharmadorf, and IDISA Group.

Differentiator

Problem solved

Functional benefit

Brands

• Sanfer ALPES: Poultry genetics company
• Sanfer IMSA
• Sanfer Salud Animal
• Sanfer Conecta
• Fundación Sanfer

Products and services

• Sanfer Conecta Free mobile application for healthcare professionals offering access to Sanfer's prescription and OTC product catalog, a virtual library of more than 300,000 medical books and articles, on-demand webinars, and interactive 3D anatomical models.
• Sanfer Salud Animal Animal health division providing live vaccines, recombinant vaccines, emulsified vaccines, bacterins, specific immunoglobulins, sterile diluents, antibiotics, antiparasitics, hormonal products, mastitis diagnostic tests, biosecurity products, antimycotoxin agents, and nutritional additives for veterinarians and animal health providers.
• Sanfer ALPES and Sanfer IMSA (Avian Genetics) Poultry genetics businesses (ALPES and IMSA) offering poultry genetic lines for the human pharmaceutical, animal health, and agricultural markets.
• AC-Fast OTC analgesic tablets containing Paracetamol 500mg, available in 10-tablet packs, for headache, muscle pain, toothache, ear pain, and fever reduction.
• Algitrin OTC analgesic for temporary relief of mild to moderate pain (headache, muscle, dental, back, menstrual, and joint pain) and fever reduction, containing Paracetamol/Ibuprofen, available in 12- and 24-tablet packs.
• Andantol OTC antihistamine (4mg tablets, jelly, gel, and syrup formulations) for effective relief of allergy symptoms such as sneezing, runny nose, watery eyes, itching in nose and throat, and urticaria.
• Biometrix Nutraceutical food supplement line based on vitamins, minerals, and ginseng, available in Performance, AOX (with antioxidants), and Q-10 (with Coenzyme Q-10 and royal jelly) formulations in 30- and 100-capsule presentations.
• Tabalón OTC anti-inflammatory analgesic containing Ibuprofen 400mg tablets for treatment of fever, inflammation, and relief of various pains including headache (including migraine), toothache, muscle pain, and premenstrual pain.
• Desenex OTC antifungal cream containing undecylenic acid and zinc undecylenate, available in 28g and 48g tubes, for treatment of dry lesions of cutaneous mycosis (tineas) affecting the skin and as auxiliary treatment of Athlete's Foot.
• Treda OTC antiseptic intestinal medication for acute diarrhea with or without infection, containing Neomycin, Kaolin, and Pectin, available in suspension (almond-cherry flavor, 75ml) and tablets (10 and 20 tablets).
• Ting OTC antifungal powder and cream for treatment of Athlete's Foot and other superficial mycoses (tineas), containing undecylenic acid, zinc undecylenate, and triclosan, available in 45g/85g/160g powder and 28g/72g cream formats.
• Syncol OTC line of products for premenstrual syndrome (PMS) and dysmenorrhea, including Syncol (Paracetamol/Pyrilamine/Pamabrom), Syncol Max, Syncol Nocturno, and Syncol Dual (Naproxen Sodium/Paracetamol).
• Optazol-KO OTC intestinal antiseptic for acute diarrhea with or without mild infection, containing Neomycin, Kaolin, and Pectin, available in suspension (75ml) and 20-tablet (129/280/30 mg) presentations.
• Mebeciclol Prescription treatment for intestinal parasitosis, containing Mebendazole and Tinidazole in 18-tablet packs of 300mg/60mg.
• Loxcell NF Prescription anti-parasitic medication for treatment of parasitosis caused by protozoa and helminths including Taenia (tapeworm), pinworm, Ascaris, and Giardia, 1 tablet of 400/300mg.
• Meta-R Metabiotics food supplement containing Lactobacillus paracasei, Lactobacillus plantarum, Lactobacillus fermentum, and polyphenol complex, presented as 90 capsules with 30 day capsules and 60 night capsules.
• Microdacyn OTC wound cleansing and healing antiseptic solution for adjuvant treatment of all types of wounds (superficial, acute, chronic, and/or deep), available in 120ml/240ml spray solution, 100g Hydrogel, and a bucopharyngeal formulation.
• Mucosolvan OTC expectorant containing Ambroxol, available in 120ml solution (300mg/100ml or 600mg/100ml), auxiliary for relief of productive cough by dissolving and helping expel phlegm.
• Bisolvon OTC expectorant containing Bromhexine for expectoration of phlegm, available in adult solution (120ml) and children's solution (120ml).
• Sinudox OTC nasal antiseptic solution auxiliary in prevention and treatment of rhinopharyngeal infections (common cold, rhinopharyngitis, rhinitis, sinusitis), nasal hygiene, and treatment of nasal surgical wounds, presented as 60ml spray.
• Eternal OTC Vitamin E antioxidant supplement containing Tocofersolan for treatment of vitamin E deficiencies, available in 30- and 99-capsule packs.
• Lonol OTC topical line for relief of muscle and joint pain, including Lonol cream (Benzydamine 60g) and Lonol Sport gel (Benzydamine, Menthol, Methyl Salicylate, 30g).
• Efpeglenatide (GLP-1 Therapy) Hanmi Pharmaceutical's GLP-1 therapy for obesity, distributed in Mexico exclusively by Laboratorios Sanfer under an exclusive distribution agreement announced in 2026. Sanfer leads regulatory approvals, marketing, and sales while Hanmi supplies the finished formulation.

Named customers9 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Two partnerships are on record, tiered core.

• Hanmi PharmaceuticalcoreStrategic or Co-development Partner · 6 February 2026Hanmi Pharmaceutical signed an exclusive distribution agreement with Laboratorios Sanfer to introduce efpeglenatide, a GLP-1 therapy for obesity, in Mexico. Sanfer leads regulatory approvals, marketing, and sales efforts in Mexico while Hanmi supplies the finished formulations. The partnership aims to address rising demand for metabolic treatments in Mexico, which has 36.86% obesity prevalence and 16.4% diabetes prevalence. Both companies plan to gradually expand collaboration on metabolic disease treatments and explore additional product launches over the medium to long term.
• Hanmi PharmaceuticalcoreStrategic or Co-development Partner · 28 January 2026Exclusive distribution agreement for Hanmi's GLP-1 obesity drug efpeglenatide and Dapalon-lineup diabetes treatments in Mexico. Hanmi supplies finished formulations while Sanfer handles regulatory approvals, marketing, and sales. Mexico's high obesity (36.86%) and diabetes (16.4%) prevalence makes it a strategically valuable market for Hanmi's independently developed GLP-1 treatment.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Genomma Lab Internacional: Mexican pharmaceutical company with a similar OTC and consumer healthcare portfolio, plus a strong Latin American distribution footprint. Highly comparable in geographic focus, customer segments (pharmacies and mass retail), and product positioning.
• Laboratorios Liomont: Mexican pharmaceutical manufacturer with a comparable product mix spanning prescription, OTC, and animal health products, and a similar focus on the Mexican and Central American markets. Closely aligned in scale, business model, and therapeutic breadth.
• Grupo PISA: One of the largest sterile injectable manufacturers in Latin America, headquartered in Mexico. Directly comparable to Sanfer following the Vitalis acquisition given its leadership in injectables manufacturing and hospital channel distribution.

Regional players

• Eurofarma Laboratórios: Brazilian multinational pharmaceutical company with broad prescription, OTC, and generics portfolio and Latin American regional presence. Comparable in business model, therapeutic breadth, and Latin American growth strategy, though primarily Brazil-anchored.
• EMS Pharma: Brazil's largest pharmaceutical company by volume, with a comprehensive generics, prescription, and OTC portfolio. Comparable as a Latin American pharma market leader with broad therapeutic coverage and mass-market distribution.
• Laboratorios Bagó: Argentine pharmaceutical multinational with operations across Latin America, manufacturing prescription and OTC products. Similar in business model and regional expansion strategy, with comparable focus on ethical pharmaceuticals across the Southern Cone.
• Roemmers: Argentine pharmaceutical group with branded prescription, OTC, and consumer health products marketed across Latin America. Comparable in pharmaceutical manufacturing, therapeutic breadth, and multi-country Latin American commercial presence.

Broad incumbents

• Sanofi: Global pharmaceutical major with a meaningful Latin American branded prescription and consumer health business. Comparable in therapeutic categories and distribution model, but operates at much greater scale with a global R&D engine.
• Bayer Pharmaceuticals: Global healthcare and pharmaceutical major with strong OTC and consumer health presence in Latin America. Comparable in OTC product categories, pharmacy distribution, and consumer health marketing, though with a far broader portfolio.
• Teva Pharmaceutical: Global leader in generics and specialty pharmaceuticals with established operations in Latin America. Comparable in prescription generics, manufacturing scale, and supply-chain capability, though far larger and more globally diversified.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks1 record

Key highlights7 records

Customer concentration

• Xtwitter.com/sanfer_mx
• YouTubeyoutube.com/@sanfermexico
• Facebookfacebook.com/SanferMexico
• LinkedInlinkedin.com/company/sanfer
• Instagraminstagram.com/sanfermexico

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries18 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sanfer